Applied BioMath uses mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk drug research and development. Their Model-Aided Drug Invention (MADI) approach employs proprietary algorithms and software to support groups worldwide in decision-making from early research through clinical trials.
The Jackson Laboratory is a leading provider of cancer mouse models and In Vivo oncology services and a National Cancer Institute-designated Cancer Center. Drawing on decades of mouse-based oncology research experience, we provide capabilities around model selection and husbandry and customizable oncology studies to help clients and researchers evaluate novel anti-cancer therapies.
Mitra Biotech is a global leader in advancing personalized cancer treatment and empowering drug development & discovery. Our phenotypic CANscript platform delivers powerful insight for our biopharma partners. Because CANscript conserves the native tumor microenvironment and delivers 1:1 clinical correlation… Read More
Nanobiotix (Euronext: NANO / ISIN: FR0011341205) is a late clinical-stage company pioneering novel nanomedicines. The first-in-class lead product NBTXR3, enhances radiotherapy energy to provide a new, more efficient treatment for cancer patients. NBTXR3 physical MOA aims to destroy tumors and may induce specific immune response compare to radiotherapy for local control and systemic therapy. It is currently in clinical development in 7 indications across oncology.
Immudex’s MHC Dextramer® products are utilized for the quantification or sorting of antigen-specific T cells in life science research, in vitro diagnostics, as well as the development of immunotherapeutics and vaccines. The primary focus is research-use-only products for the immune monitoring of immunotherapy development, and monitoring of… Read more
Caprion provides GCP/GLP/GCLP immune monitoring and proteomics services to 50+ major companies in the pharmaceutical and biotechnology industry for their vaccine and immunotherapy programs. Caprion’s immune monitoring business unit, ImmuneCarta®, offers proprietary multiparametric flow…Read More
Personal Genome Diagnostics (PGDx) advances the frontiers of cancer medicine through innovative genomic technologies for oncology researchers, drug developers, clinicians and patients. The expert team at PGDx draws on a deep understanding of cancer biology, extensive experience in cancer genomics and clinical oncology, and the company’s distinctive technologies.